Pronto to Distribute Signal's Myeloma Test

Signal Genetics' CEO J said the deal "represents our initial entry into the international market with MyPRS and strong interest among both laboratories and physicians outside the United States in providing broader access to this novel technology."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.